Qiming U.S. Ventures Management »

Tourmaline Bio shares owned by Qiming U.S. Ventures Management

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by Qiming U.S. Ventures Management from 13F filings

Historical chart of Qiming U.S. Ventures Management investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by Qiming U.S. Ventures Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by Qiming U.S. Ventures Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 642k 26.18

More positions owned by Qiming U.S. Ventures Management

Icosavax
Korro Bio (KRRO)
Tourmaline Bio (TRML)
Hillevax (HLVX)
Jasper Therapeutics
Ventyx Biosciences (VTYX)
Elevation Oncology (ELEV)
Kezar Life Sciences (KZR)

View all positions for Qiming U.S. Ventures Management

Top funds holding Tourmaline Bio

Blue Owl Capital Holdings
Jennison Associates
QVT Financial
Vanguard Group
Braidwell
venBio Select Advisor
Dr. Jeffrey R. Jay, M.D.
Qiming U.S. Ventures Management
Vivo Capital
Nantahala Capital Management
Balyasny Asset Management
Logos Global Management
Susquehanna International
Artal Group
AlphaCentric Advisors

View all funds holding Tourmaline Bio